Boston Scientific Net Income 2010-2023 | BSX
Boston Scientific annual/quarterly net income history and growth rate from 2010 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Boston Scientific net income for the quarter ending December 31, 2023 was $0.504B, a 303.2% increase year-over-year.
- Boston Scientific net income for the twelve months ending December 31, 2023 was $1.570B, a 144.55% increase year-over-year.
- Boston Scientific annual net income for 2023 was $1.57B, a 144.55% increase from 2022.
- Boston Scientific annual net income for 2022 was $0.642B, a 34.82% decline from 2021.
- Boston Scientific annual net income for 2021 was $0.985B, a 956.52% decline from 2020.
| Boston Scientific Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $1,570 |
| 2022 | $642 |
| 2021 | $985 |
| 2020 | $-115 |
| 2019 | $4,700 |
| 2018 | $1,671 |
| 2017 | $104 |
| 2016 | $347 |
| 2015 | $-239 |
| 2014 | $-119 |
| 2013 | $-121 |
| 2012 | $-4,068 |
| 2011 | $441 |
| 2010 | $-1,065 |
| 2009 | $-1,025 |
| Boston Scientific Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2023-12-31 | $504 |
| 2023-09-30 | $505 |
| 2023-06-30 | $261 |
| 2023-03-31 | $300 |
| 2022-12-31 | $125 |
| 2022-09-30 | $174 |
| 2022-06-30 | $246 |
| 2022-03-31 | $97 |
| 2021-12-31 | $81 |
| 2021-09-30 | $405 |
| 2021-06-30 | $172 |
| 2021-03-31 | $327 |
| 2020-12-31 | $196 |
| 2020-09-30 | $-169 |
| 2020-06-30 | $-153 |
| 2020-03-31 | $11 |
| 2019-12-31 | $3,996 |
| 2019-09-30 | $126 |
| 2019-06-30 | $154 |
| 2019-03-31 | $424 |
| 2018-12-31 | $386 |
| 2018-09-30 | $432 |
| 2018-06-30 | $555 |
| 2018-03-31 | $298 |
| 2017-12-31 | $-615 |
| 2017-09-30 | $283 |
| 2017-06-30 | $146 |
| 2017-03-31 | $290 |
| 2016-12-31 | $124 |
| 2016-09-30 | $228 |
| 2016-06-30 | $-207 |
| 2016-03-31 | $202 |
| 2015-12-31 | $-142 |
| 2015-09-30 | $-198 |
| 2015-06-30 | $102 |
| 2015-03-31 | $-1 |
| 2014-12-31 | $-299 |
| 2014-09-30 | $43 |
| 2014-06-30 | $4 |
| 2014-03-31 | $133 |
| 2013-12-31 | $108 |
| 2013-09-30 | $-5 |
| 2013-06-30 | $130 |
| 2013-03-31 | $-354 |
| 2012-12-31 | $61 |
| 2012-09-30 | $-664 |
| 2012-06-30 | $-3,578 |
| 2012-03-31 | $113 |
| 2011-12-31 | $107 |
| 2011-09-30 | $142 |
| 2011-06-30 | $146 |
| 2011-03-31 | $46 |
| 2010-12-31 | $236 |
| 2010-09-30 | $190 |
| 2010-06-30 | $98 |
| 2010-03-31 | $-1,589 |
| 2009-12-31 | $-1,076 |
| 2009-09-30 | $-94 |
| 2009-06-30 | $158 |
| 2009-03-31 | $-13 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $107.805B | $14.240B |
| Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.877B | 24.14 |
| Stryker (SYK) | United States | $128.028B | 30.70 |
| Medtronic (MDT) | Ireland | $106.544B | 15.08 |
| EssilorLuxottica (ESLOY) | France | $97.060B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.204B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.949B | 30.46 |
| ResMed (RMD) | United States | $31.437B | 29.52 |
| Terumo (TRUMY) | Japan | $25.223B | 35.62 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.713B | 15.91 |
| Koninklijke Philips (PHG) | Netherlands | $24.656B | 19.10 |
| Baxter (BAX) | United States | $20.501B | 14.95 |
| Insulet (PODD) | United States | $12.040B | 63.21 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.549B | 0.00 |
| Demant (WILYY) | Denmark | $10.525B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.693B | 22.92 |
| BellRing Brands (BRBR) | United States | $7.226B | 38.85 |
| Haemonetics (HAE) | United States | $4.670B | 23.88 |
| Lantheus Holdings (LNTH) | United States | $4.561B | 11.78 |
| Perrigo (PRGO) | Ireland | $4.426B | 12.66 |
| GN Store Nord (GNNDY) | Denmark | $4.097B | 26.53 |
| Prestige Consumer Healthcare (PBH) | United States | $3.563B | 16.84 |
| Envista Holdings (NVST) | United States | $3.382B | 12.86 |
| Green Thumb Industries (GTBIF) | United States | $3.229B | 102.33 |
| QuidelOrtho (QDEL) | United States | $2.712B | 9.84 |
| Neogen (NEOG) | United States | $2.671B | 25.69 |
| ICU Medical (ICUI) | United States | $2.386B | 17.80 |
| Verano Holdings (VRNOF) | United States | $2.161B | 0.00 |
| TG Therapeutics (TGTX) | United States | $2.111B | 683.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.061B | 0.00 |
| Owens & Minor (OMI) | United States | $1.895B | 18.19 |
| Agios Pharmaceuticals (AGIO) | United States | $1.845B | 0.00 |
| Canopy Growth (CGC) | Canada | $1.491B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.455B | 48.00 |
| InMode (INMD) | Israel | $1.444B | 7.47 |
| National Vision Holdings (EYE) | United States | $1.364B | 42.49 |
| AdaptHealth (AHCO) | United States | $1.309B | 9.85 |
| AtriCure (ATRC) | United States | $1.167B | 0.00 |
| Warby Parker (WRBY) | United States | $1.163B | 0.00 |
| MacroGenics (MGNX) | United States | $0.925B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.857B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.795B | 0.00 |
| Evolus (EOLS) | United States | $0.737B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.676B | 14.65 |
| VAREX IMAGING (VREX) | United States | $0.660B | 14.25 |
| TerrAscend (TSNDF) | Canada | $0.635B | 0.00 |
| Quanterix (QTRX) | United States | $0.617B | 0.00 |
| Jin Medical (ZJYL) | China | $0.591B | 0.00 |
| Valneva SE (VALN) | France | $0.519B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.503B | 0.00 |
| PetIQ (PETQ) | United States | $0.480B | 17.93 |
| ZimVie (ZIMV) | United States | $0.414B | 25.33 |
| Biote (BTMD) | United States | $0.411B | 3.91 |
| OraSure Technologies (OSUR) | United States | $0.405B | 6.70 |
| Surmodics (SRDX) | United States | $0.366B | 39.52 |
| Zynex (ZYXI) | United States | $0.353B | 47.70 |
| Viemed Healthcare (VMD) | United States | $0.318B | 31.50 |
| Cerus (CERS) | United States | $0.309B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.263B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.249B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 14.71 |
| Organigram Holdings (OGI) | Canada | $0.219B | 0.00 |
| Veru (VERU) | United States | $0.198B | 0.00 |
| Omeros (OMER) | United States | $0.183B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.171B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.166B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.165B | 83.00 |
| Quipt Home Medical (QIPT) | United States | $0.153B | 0.00 |
| InterCure (INCR) | Israel | $0.133B | 22.46 |
| FitLife Brands (FTLF) | United States | $0.128B | 20.55 |
| MariMed (MRMD) | United States | $0.122B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.111B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 8.55 |
| Allurion Technologies (ALUR) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Brainsway (BWAY) | Israel | $0.087B | 0.00 |
| Chimerix (CMRX) | United States | $0.084B | 0.00 |
| Safety Shot (SHOT) | United States | $0.075B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.062B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.053B | 3.47 |
| Apyx Medical (APYX) | United States | $0.050B | 0.00 |
| Bright Green (BGXX) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.66 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 0.00 |
| Flora Growth (FLGC) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.016B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |